Immunoblot analysis of these pathways confirmed the findings of the phosphoprotein array, suggesting that STAT3 is activated independent of EGFR in these NSCLC cells (Fig. 1C). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.